National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
What You Need To Know About™ Liver Cancer
    Posted: 02/08/2002    Updated: 09/16/2002



Introduction






The Liver






Understanding Cancer






Liver Cancer: Who's at Risk?






Symptoms






Diagnosis






Staging






Treatment






Getting a Second Opinion






Treatment Choices






Localized resectable cancer






Localized unresectable cancer






Advanced cancer







Recurrent cancer






Side Effects of Treatment






Pain Control






Nutrition






Continuing Care






Support for People with Liver Cancer






The Promise of Cancer Research






National Cancer Institute Booklets






National Cancer Institute Information Resources



Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
PDF Version  View/Print PDF
Order Free Copy  Order Free Copy
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Recurrent cancer

Recurrent cancer means the disease has come back after the initial treatment. Even when a tumor in the liver seems to have been completely removed or destroyed, the disease sometimes returns because undetected cancer cells remained somewhere in the body after treatment. Most recurrences occur within the first 2 years of treatment. The patient may have surgery or a combination of treatments for recurrent liver cancer.

These are some questions a person may want to ask the doctor before treatment begins:
  • Is there any evidence the cancer has spread? What is the stage of the disease?

  • Do I need any more tests to determine whether I can have surgery?

  • What are my treatment choices? Which do you recommend for me? Why?

  • What are the expected benefits of each kind of treatment?

  • What are the risks and possible side effects of each treatment?

  • Will I need to stay in the hospital?

  • How will you treat my pain?

  • What is the treatment likely to cost? Is this treatment covered by my insurance plan?

  • How will treatment affect my normal activities?

  • Would a clinical trial (research study) be appropriate for me?

People do not need to ask all of their questions or understand all of the answers at once. They will have other chances to ask the health care team to explain things that are not clear and to ask for more information.

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov